Department of Psychiatry, Oman Medical Specialty Board, Muscat, Oman.
Department of Medicine, Sultan Qaboos University Hospital, Muscat, Oman.
Sultan Qaboos Univ Med J. 2022 Aug;22(3):409-412. doi: 10.18295/squmj.6.2021.090. Epub 2022 Aug 25.
Guillain-Barré syndrome (GBS) has been reported as one of the neurological manifestations linked to COVID-19, a severe acute respiratory syndrome caused by coronavirus 2. We present the case of a 72-year-old male patient attending a tertiary care hospital in Muscat, Oman, in 2020 with a history of progressive bilateral limb weakness and numbness. The current diagnosis was in line with a rare complication of COVID-19. After exclusion of other possible causes, a diagnosis of GBS induced by COVID-19 was made. The patient received 0.4g/kg of intravenous immunoglobulin (IVIG) per day for five days. This case report highlights the characteristics and course of GBS following COVID-19 infection. Further studies are needed to characterize the manifestations and course of various neuromuscular disorders in relation to COVID-19 infection.
格林-巴利综合征（GBS）已被报道为与 COVID-19 相关的一种神经系统表现之一，COVID-19 是由冠状病毒 2 引起的严重急性呼吸系统综合征。我们报告了 2020 年在阿曼马斯喀特的一家三级护理医院就诊的一位 72 岁男性患者的病例，该患者有进行性双侧肢体无力和麻木的病史。目前的诊断与 COVID-19 的一种罕见并发症一致。在排除其他可能的原因后，诊断为 COVID-19 引起的 GBS。患者每天接受 0.4g/kg 的静脉注射免疫球蛋白（IVIG），共五天。本病例报告强调了 COVID-19 感染后 GBS 的特征和病程。需要进一步的研究来描述与 COVID-19 感染相关的各种神经肌肉疾病的表现和病程。
